Funder: Vertex Pharmaceuticals
Due Dates: Rolling (most programs) | 2026 (next cycle for select CF award programs)
Funding Amounts: No fixed cap; CF Research Innovation Awards: up to $750,000 over 3 years; Mentored RIA: up to $125,000 over 2 years; VIA: up to $750,000 per project.
Summary: Supports independent research, education, and advocacy initiatives in serious diseases (notably cystic fibrosis), with rolling submissions and specialized award cycles.
Key Information: Requests must align with Vertex’s disease priorities; some programs accept proposals only during RFP windows.